Article ID | Journal | Published Year | Pages | File Type |
---|---|---|---|---|
9942448 | The American Journal of the Medical Sciences | 2005 | 4 Pages |
Abstract
Our results indicate that multidisciplinary treatment, including surgery, radiotherapy, and chemotherapy, is beneficial in treating primary thymic carcinoma. Chemotherapy plays an important role in both primary and relapsed stage IV thymic carcinoma in terms of prolonging the disease-free survival and median survival of patients with lymphoepithelioma-like or squamous cell histology types. For patients with an undifferentiated histology, multidisciplinary treatment or chemotherapy might not be helpful in either primary or relapsed stage IV thymic carcinoma.
Keywords
Related Topics
Health Sciences
Medicine and Dentistry
Cardiology and Cardiovascular Medicine
Authors
Jen-Tsun MD, Wang MD, Chueh-Chuan MD, Jin-Huang MD, Po-Min MD, Tzeon-Jye MD,